Lab result explainedBlood count (CBC)Last updated November 8, 2026

Reticulocyte count: what a high or low retic count means

Reticulocyte count (Retic) · Reticulocyte count (ordered with or added to a CBC) · reported in Percent of red blood cells (%), and absolute count in cells/µL (×10⁹/L); corrected count and reticulocyte production index (RPI) are unitless

Reticulocytes are red blood cells that left the bone marrow within the past one to two days and still contain a few strands of RNA; the reticulocyte count measures how many of them are in your blood, and so how fast your marrow is making red cells right now. Normal is about 0.5 to 2.5 percent of red cells, or 25,000 to 100,000 cells per microlitre as an absolute count. Because a mature red cell lives about 120 days, a healthy marrow replaces roughly one percent of them a day, which is where the normal percentage comes from.

The test is almost always ordered to sort out anemia. A high reticulocyte count in an anemic person means the marrow is working hard and the cells are being lost elsewhere, by bleeding or by destruction (hemolysis). A low or normal count in an anemic person means the marrow itself is not producing enough, because it lacks a raw material (iron, vitamin B12, folate), lacks the hormone that drives it (erythropoietin from the kidneys), is suppressed by inflammation, alcohol or a drug, or is diseased. This single division is the first branch point in every anemia work-up.

The count also tracks recovery. Within three to five days of starting iron, B12 or folate in someone who was deficient, or of stopping a marrow-suppressing drug, reticulocytes rise sharply and peak at day seven to ten, well before the hemoglobin moves. A reticulocyte count that fails to rise after a week of treatment means the diagnosis or the treatment is wrong. Newer analyzers also report the immature reticulocyte fraction and the reticulocyte hemoglobin content, which show marrow activity and iron supply even earlier.

Retic at a glance

What it is: the percentage (or absolute number) of red blood cells released from the marrow in the last 1 to 2 days; a direct measure of red cell production.
Normal (adults): about 0.5–2.5% of red cells; absolute count about 25,000–100,000/µL (25–100 ×10⁹/L). Newborns run 3–7%. Labs differ.
In anemia the raw percentage overstates production, so it is corrected for hematocrit (reticulocyte index) and for early release (reticulocyte production index, RPI): an RPI below 2 means the marrow is underproducing; above 2 to 3 means it is responding appropriately.
High retic count: the marrow is compensating for blood loss or hemolysis (sickle cell disease, autoimmune hemolysis, G6PD deficiency, spherocytosis), or responding to treatment for a deficiency.
Low retic count with anemia: iron, B12 or folate deficiency, kidney disease, anemia of chronic disease, bone marrow failure or suppression by drugs, alcohol or infection.
Next step: read with hemoglobin, MCV, ferritin, B12, folate, bilirubin, LDH and haptoglobin; a retic count that has not risen 7 to 10 days into treatment means the plan needs revisiting.

Have your whole report? Paste it into the free Lab Explainer

Every marker explained in plain language, in context with the others, with questions to bring to your appointment. No account needed.

What Retic measures

As a red cell precursor matures in the marrow it ejects its nucleus but keeps some ribosomal RNA for a day or two, during which it is a reticulocyte. Analyzers stain this RNA with a fluorescent dye and count the cells that light up as a percentage of all red cells, then multiply by the red cell count to give an absolute number. The manual method, counting cells with a blue-stained mesh (reticulum) under the microscope after supravital staining, gave the cell its name and is still used as a check.

The percentage is misleading when the red cell count is low, because the same number of reticulocytes is a larger fraction of fewer cells. The corrected reticulocyte count (reticulocyte index) adjusts for this: retic percentage multiplied by the patient's hematocrit divided by 45. A second correction is needed because an anemic, erythropoietin-stimulated marrow releases reticulocytes early, so they circulate for 2 to 3 days instead of 1, doubling the count without doubling production; dividing by a maturation factor (1.0 at hematocrit 45, 1.5 at 35, 2.0 at 25, 2.5 at 15) gives the reticulocyte production index. Example: hematocrit 24 percent and reticulocytes 9 percent gives a corrected count of 4.8 and an RPI of 2.4, an appropriate response; hematocrit 24 percent and reticulocytes 2 percent gives an RPI of 0.5, an underproducing marrow.

Modern analyzers also report the immature reticulocyte fraction (IRF), the proportion with the most RNA, which rises within 24 to 48 hours of marrow recovery after chemotherapy or a transplant, and the reticulocyte hemoglobin content (Ret-He or CHr), the amount of hemoglobin in these newest cells. A Ret-He below about 28 to 29 pg indicates the marrow is short of iron today, whereas ferritin and the MCV reflect the past weeks to months; it rises within 2 to 4 days of effective iron treatment and is used to monitor iron therapy in kidney disease.

Normal range for Retic

Reference ranges vary between labs and by age, sex and pregnancy. Use the range printed on your own report.

Group	Typical range (Percent of red blood cells (%), and absolute count in cells/µL (×10⁹/L); corrected count and reticulocyte production index (RPI) are unitless)	Notes
Adults, normal	About 0.5–2.5% (some labs 0.5–1.5% or 0.5–2.0%)	Absolute count about 25,000–100,000/µL. Labs differ; use the range on your report.
Newborns	About 3–7% in the first days of life	Falls to adult levels by 2 to 3 months, then may rise slightly during the first-year growth spurt.
Pregnancy	Mildly raised, about 1–3%	Red cell mass expands by 20 to 30 percent, so production is higher.
Reticulocyte production index, adequate response	RPI above 2 (some clinicians use above 3)	The marrow is responding to anemia appropriately: bleeding, hemolysis or recovery from a deficiency.
Reticulocyte production index, inadequate response	RPI below 2 in the presence of anemia	Hypoproliferative anemia: nutritional deficiency, kidney disease, inflammation, marrow suppression or marrow disease.
Marked reticulocytosis	Above 5% (often 10–20%, occasionally higher)	Brisk hemolysis, acute hemorrhage 3 to 7 days earlier, or the peak response 7 to 10 days after starting iron, B12 or folate in deficiency.
Severe aplastic anemia threshold	Absolute count below 60,000/µL (older criteria below 20,000/µL) with low neutrophils and platelets	Part of the Camitta criteria used with marrow cellularity below 25 percent.
Reticulocyte hemoglobin content (Ret-He / CHr)	About 28–35 pg normal; below 28–29 pg suggests iron-restricted red cell production	Reflects iron available to the marrow in the last few days; used to guide iron therapy in chronic kidney disease.
Immature reticulocyte fraction (IRF)	Roughly 3–15% depending on analyzer	Rises early in marrow recovery after chemotherapy or transplant; high with hemolysis; low in aplastic states.

High reticulocyte count (reticulocytosis)

A high reticulocyte count means the marrow is producing red cells faster than normal. In someone who is anemic, that is reassuring about the marrow and shifts attention to where the cells are going: either out of the body (bleeding) or being destroyed in the circulation or spleen (hemolysis). Hemolysis is confirmed by a raised unconjugated bilirubin and lactate dehydrogenase (LDH), a low haptoglobin and, in immune hemolysis, a positive direct antiglobulin (Coombs) test; the blood film shows spherocytes, fragments or sickle cells depending on the cause.

Timing matters after a bleed. In the first day or two after acute blood loss the reticulocyte count is normal because the marrow has not yet geared up; it rises from day three, peaks around day five to seven and returns to normal once the hemoglobin recovers, provided iron stores hold out. Chronic slow bleeding exhausts iron and the count then falls, so a normal reticulocyte count does not exclude blood loss. Similarly, a surge in reticulocytes 5 to 10 days after starting iron, B12 or folate (the reticulocyte crisis, often to 5 to 15 percent) is the expected proof that the treatment is working and the diagnosis was right.

A high count without anemia usually reflects a healthy marrow responding to a mild, compensated stimulus: altitude, recent blood donation, intense training, pregnancy, erythropoietin or testosterone treatment, or a chronic low-grade hemolysis such as hereditary spherocytosis or a mechanical heart valve where production keeps pace with destruction. Polycythemia vera can run a modestly high count. People with sickle cell disease live with a steady-state reticulocyte count of 5 to 15 percent, and a sudden fall toward zero in them signals an aplastic crisis.

Common causes

Hemolytic anemia (autoimmune)
Warm or cold autoantibodies coat red cells, which the spleen removes early. Reticulocytes run 5 to 20 percent, bilirubin and LDH are high, haptoglobin is undetectable and the direct antiglobulin test is positive. Triggers include lupus, lymphoma, chronic lymphocytic leukemia, infections and drugs.
Sickle cell disease and other inherited hemolytic anemias
Sickle cell disease (steady-state reticulocytes 5 to 15 percent), hereditary spherocytosis (5 to 20 percent), G6PD deficiency during an oxidative crisis, pyruvate kinase deficiency and thalassemia intermedia all destroy cells early and the marrow compensates.
Acute blood loss
After trauma, surgery, a bleeding ulcer or heavy menstrual loss the count rises from day three, peaks at day five to seven and may reach 5 to 10 percent before settling as hemoglobin recovers. Ongoing bleeding with falling iron stores blunts the response.
Response to treatment of a deficiency
Iron, vitamin B12 or folate given to someone who is deficient produces a reticulocyte peak at day 7 to 10, often 5 to 15 percent after iron and 10 to 25 percent after B12 in pernicious anemia. Failure to see this rise means the diagnosis, dose, absorption or compliance needs checking.
Mechanical and microangiopathic hemolysis
Leaking mechanical heart valves, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, disseminated intravascular coagulation, severe hypertension and march hemoglobinuria in long-distance runners fragment red cells; the film shows schistocytes and platelets are often low.
Recovery of the marrow
After chemotherapy, radiotherapy, a marrow transplant or an aplastic crisis, reticulocytes (and especially the immature reticulocyte fraction) rise 1 to 3 days before neutrophils and platelets, signalling engraftment or recovery.
Erythropoietin, testosterone and hypoxia
Erythropoiesis-stimulating agents in kidney disease, testosterone therapy, living or training at altitude, sleep apnea, lung disease and heavy smoking all stimulate production and raise the count modestly, usually to 2 to 4 percent.
Infection-related and drug-induced hemolysis
Malaria, Clostridium perfringens sepsis, mycoplasma (cold agglutinins), and drugs such as dapsone, primaquine, high-dose penicillins, cephalosporins, ribavirin and methyldopa shorten red cell survival.
Hypersplenism
An enlarged spleen from cirrhosis, lymphoma or storage disorders traps and destroys red cells prematurely, producing a mild compensated hemolysis with a raised count and low platelets and white cells.

Symptoms that can go with it

Fatigue, breathlessness and pallor from the underlying anemia
Yellowing of the skin or whites of the eyes (jaundice) and dark, tea-coloured urine with hemolysis
A full or aching feeling under the left ribs from an enlarged spleen
Gallstones and right-sided abdominal pain in long-standing hemolysis
Black or bloody stools, heavy periods or vomiting blood if the cause is bleeding
Back pain, fever and dark urine during an acute hemolytic episode
Often no symptoms when the count is mildly raised in a healthy person at altitude or in training

Low reticulocyte count (reticulocytopenia)

A low reticulocyte count only matters in context. In someone with a normal hemoglobin, a count of 0.5 percent is simply the lower end of normal. In someone who is anemic, a low or even 'normal' count is abnormal, because a healthy marrow should be producing two to three times the usual number of cells to compensate; the reticulocyte production index makes this explicit. A low count with anemia therefore means hypoproliferative anemia: the marrow is not making enough red cells.

The commonest reasons are nutritional. Iron deficiency, the most frequent cause of anemia worldwide, produces small pale cells and a low count; vitamin B12 and folate deficiency produce large cells and, counter-intuitively, a low count, because the defective precursors die inside the marrow before they are released (ineffective erythropoiesis). Chronic kidney disease lowers the count by removing the erythropoietin signal, and anemia of chronic disease or inflammation lowers it by locking iron away and blunting the marrow's response to erythropoietin. Alcohol, hypothyroidism and many medications suppress production more modestly.

The most serious causes are in the marrow itself. Aplastic anemia, myelodysplastic syndromes, leukemia, myeloma, myelofibrosis and cancer infiltrating bone all reduce output, usually with low white cells and platelets as well. Pure red cell aplasia, from parvovirus B19 infection (which in sickle cell disease or spherocytosis causes a sudden aplastic crisis with reticulocytes near zero), thymoma, drugs or autoantibodies, shuts down red cell production alone. A very low count with anemia and other abnormal cell lines is a reason for a prompt blood film and often a bone marrow examination.

Common causes

Iron deficiency
Without iron the marrow cannot make hemoglobin and output falls; cells are small (low MCV) with a high RDW, ferritin is below 30 ng/mL and reticulocyte hemoglobin is low. The count rises within 3 to 5 days of adequate iron, which is the therapeutic test.
Vitamin B12 or folate deficiency
DNA synthesis fails, precursors die in the marrow, and the count is low despite a cellular marrow (ineffective erythropoiesis). Cells are large (MCV often above 100 fL), LDH and bilirubin may be mildly raised, and the count surges 5 to 8 days after replacement begins.
Chronic kidney disease
Erythropoietin production falls as kidney function declines, so the marrow receives no signal to increase output despite anemia; cells are normal in size and the count is inappropriately normal or low. Erythropoiesis-stimulating agents raise it within a week.
Anemia of chronic disease (inflammation)
Rheumatoid arthritis, inflammatory bowel disease, chronic infection, heart failure and cancer raise hepcidin, trapping iron in stores, and cytokines blunt the erythropoietin response. Ferritin is normal or high, iron saturation low, and the count low-normal.
Aplastic anemia and bone marrow failure
Immune destruction of marrow stem cells, inherited syndromes, benzene, radiation and drugs (chloramphenicol, some anticonvulsants, gold) leave an empty marrow. Absolute reticulocytes below 60,000/µL with neutrophils below 500 and platelets below 20,000 define severe disease.
Myelodysplastic syndromes, leukemia and marrow infiltration
Abnormal clones crowd out or disable normal precursors; the count is low, red cells may be large, and white cells and platelets are usually abnormal. Lymphoma, myeloma and metastatic breast, prostate or lung cancer infiltrating bone do the same.
Pure red cell aplasia and parvovirus B19
Parvovirus B19 infects red cell precursors and halts production for 7 to 10 days; harmless in most people, but in sickle cell disease, spherocytosis or thalassemia, where red cells live only days to weeks, hemoglobin crashes (aplastic crisis). Chronic pure red cell aplasia occurs with thymoma, autoimmune disease and some drugs.
Chemotherapy, radiotherapy and marrow-suppressing drugs
Cytotoxic drugs, azathioprine, methotrexate, mycophenolate, zidovudine, linezolid, interferon and high-dose trimethoprim suppress production; the count falls within days of starting and is the first to recover when they are stopped.
Alcohol excess
Alcohol is directly toxic to red cell precursors and causes folate deficiency; the result is a mild macrocytic anemia with a low count that improves within 2 to 4 weeks of abstinence.
Hypothyroidism and other endocrine deficiency
Low thyroid hormone, low testosterone, adrenal insufficiency and pituitary failure reduce erythropoietin drive and marrow activity, giving a mild hypoproliferative anemia that corrects with hormone replacement.

Symptoms that can go with it

Fatigue, weakness and breathlessness on exertion from anemia
Pallor, dizziness and a fast heartbeat
Sore tongue, numbness, tingling and unsteadiness with B12 deficiency
Brittle nails, hair thinning, ice cravings and restless legs with iron deficiency
Frequent infections, mouth ulcers or fever if white cells are also low
Easy bruising, nosebleeds and bleeding gums if platelets are also low
Sudden severe weakness, pallor and fainting in someone with sickle cell disease or spherocytosis (aplastic crisis)

Read it alongside

Hemoglobin and hematocrit — define whether anemia is present and are needed to calculate the corrected count and reticulocyte production index.
MCV and RDW — small cells with a low count point to iron deficiency or thalassemia; large cells with a low count to B12, folate, alcohol or myelodysplasia; a high RDW suggests mixed or nutritional causes.
Ferritin and iron saturation — the low retic count of iron deficiency is confirmed by a ferritin below 30 ng/mL; a Ret-He below 28 pg shows iron-restricted production in real time.
Vitamin B12 and folate — the low retic count with large cells of megaloblastic anemia; expect a reticulocyte surge within a week of replacement.
Bilirubin (unconjugated), LDH and haptoglobin — the hemolysis triad that explains a high count: high bilirubin and LDH with low haptoglobin.
Direct antiglobulin (Coombs) test and blood film — identify immune hemolysis, spherocytes, fragments, sickle cells or blasts.
Creatinine and eGFR — a low count with normocytic anemia and an eGFR below 45 mL/min points to kidney-related erythropoietin deficiency.
White cell and platelet counts — if all three lines are low alongside a low reticulocyte count, the problem is the marrow or the spleen.

What usually happens next

Your clinician will place the result into one of two groups: a high count (RPI above 2) leads to hemolysis tests (bilirubin, LDH, haptoglobin, Coombs test, blood film) and a search for bleeding; a low count (RPI below 2) leads to ferritin, iron saturation, B12, folate, kidney function, thyroid function and a medication review.
If a deficiency is found and treated, expect a repeat reticulocyte count or CBC at 7 to 14 days; a rise to 3 to 10 percent confirms the response, and hemoglobin should then climb by about 1 g/dL every 2 to 3 weeks.
If the count has not risen after 10 to 14 days of treatment, the questions are whether the supplement is being absorbed (celiac disease, H. pylori, acid-suppressing drugs, taking iron with tea or calcium), whether the dose is adequate, whether bleeding is continuing and whether the diagnosis is right.
A low count with anemia and low white cells or platelets, or any abnormal cells on the film, usually leads to hematology referral and a bone marrow aspirate and biopsy.
If you have sickle cell disease, spherocytosis or another chronic hemolytic condition, know your usual reticulocyte count; a sudden fall with worsening anemia, especially after a febrile illness or contact with a child with 'slapped cheek' rash, needs same-day assessment.

Diet, lifestyle and natural levers with evidence

What can move Retic once the cause is known. Nothing here replaces finding the cause.

Iron: food sources with vitamin C, and a supplement when deficient

Strong evidence

In iron-deficiency anemia, oral iron produces a reticulocyte rise within 3 to 5 days and a peak at day 7 to 10, followed by a hemoglobin gain of about 1 g/dL every 2 to 3 weeks; trials typically used 60 to 120 mg of elemental iron a day, and randomised studies show that a single dose on alternate days is absorbed about a third more efficiently per dose than daily dosing, with fewer stomach side effects and a similar hemoglobin response over 2 to 3 months. Heme iron from meat, poultry and fish is absorbed at 15 to 35 percent; non-heme iron from legumes, tofu, fortified cereals and greens at 2 to 20 percent, roughly doubled or tripled when 50 to 100 mg of vitamin C is eaten in the same meal. Diet alone maintains stores but rarely corrects established anemia quickly.

Only supplement after ferritin confirms deficiency; iron is harmful in hemochromatosis and thalassemia and does nothing for anemia of other causes. Take it 1 to 2 hours away from tea, coffee, calcium, antacids and acid-suppressing drugs. Keep away from children, for whom overdose is dangerous.

Vitamin B12 replacement when deficient

Strong evidence

In B12-deficiency anemia the reticulocyte count surges to 10 to 25 percent between day 5 and 8 of treatment and hemoglobin normalises over 6 to 8 weeks. High-dose oral B12 (1,000 to 2,000 µg daily) raised serum B12 and corrected blood counts as effectively as intramuscular injections in randomised trials, including in pernicious anemia, because about 1 percent is absorbed passively without intrinsic factor. Injections are preferred when there are neurological symptoms or absorption is unreliable.

Never treat with folate alone when B12 status is unknown: folate can correct the blood count while B12-related nerve damage progresses.

Folate from leafy greens, legumes and fortified grains, or a supplement

Strong evidence

Folate deficiency anemia responds to 400 µg to 1 mg of folic acid daily with a reticulocyte peak at day 5 to 8 and a normal hemoglobin within 1 to 2 months; the fortification of grain products in the United States since 1998 roughly halved the prevalence of low folate. Needs are higher in pregnancy, chronic hemolysis (where the marrow consumes folate rapidly, which is why people with sickle cell disease are routinely prescribed it), alcohol excess and on methotrexate or anticonvulsants.

Timing iron away from tea, coffee and calcium

Moderate evidence

Single-meal absorption studies show black tea taken with a meal cuts non-heme iron absorption by 60 to 90 percent through its polyphenols, coffee by about 40 to 60 percent, and 300 to 600 mg of calcium (a large glass of milk or a calcium tablet) by roughly half. Leaving a gap of 1 to 2 hours between these and an iron-rich meal or supplement removes most of the effect; adding vitamin C partly counteracts it. Over months this changes how quickly ferritin and the reticulocyte response recover in people on oral iron.

Cooking in cast-iron pans

Moderate evidence

Acidic or long-simmered foods pick up several milligrams of iron per serving from cast-iron cookware. A randomised trial in Ethiopian children found cooking in iron pots raised hemoglobin by about 1.3 g/dL more than aluminium pots over 12 months, and a systematic review of trials in low-income settings found a positive effect on hemoglobin in most, though a Cambodian 'iron fish' trial was negative. The effect is modest and most useful as a maintenance measure where dietary iron is low.

Not appropriate for people with hemochromatosis or thalassemia, who should not add iron.

Reducing alcohol

Moderate evidence

Alcohol suppresses red cell precursors directly, impairs folate absorption and metabolism and causes vacuolated precursors and ring sideroblasts in the marrow. In heavy drinkers the reticulocyte count and MCV improve within 2 to 4 weeks of abstinence and hemoglobin follows over 2 to 3 months, often without any other treatment. Moderate drinking (within national guidelines) has no measurable effect on red cell production.

When to see a clinician promptly

A sudden fall in hemoglobin with a reticulocyte count near zero in someone with sickle cell disease, hereditary spherocytosis or thalassemia, especially after a fever or rash: aplastic crisis can require urgent transfusion.
Jaundice, dark urine, fever and back pain with a high reticulocyte count, or a hemoglobin falling by more than 1 to 2 g/dL in days: acute hemolysis needs same-day assessment.
A hemoglobin below 7 to 8 g/dL, or any anemia with chest pain, breathlessness at rest, fainting or a racing heart.
A low reticulocyte count together with low white cells or platelets, easy bruising, frequent infections, bone pain or night sweats, which suggests a marrow disorder.
Black or bloody stools, vomiting blood or heavy ongoing bleeding alongside an abnormal count.
No rise in the reticulocyte count 10 to 14 days after starting treatment for a diagnosed deficiency, so the plan can be reviewed.

Frequently asked questions

What is a normal reticulocyte count?

For adults, about 0.5 to 2.5 percent of red blood cells, or roughly 25,000 to 100,000 cells per microlitre as an absolute count; some laboratories use narrower limits such as 0.5 to 1.5 percent. Newborns run 3 to 7 percent and pregnant women slightly above the adult range. In someone who is anemic, a 'normal' percentage is actually too low, because the marrow should be producing more than usual to compensate.

What does a high reticulocyte count mean?

It means your bone marrow is making red cells faster than normal. If you are anemic, that points to blood being lost (bleeding) or destroyed (hemolysis) rather than to a marrow problem, and bilirubin, LDH, haptoglobin and a Coombs test are the next step. If you have recently started iron, B12 or folate for a deficiency, a high count 5 to 10 days later is the expected sign the treatment is working. If you are not anemic, mild elevation is common at altitude, after blood donation, in pregnancy or with hard training.

What does a low reticulocyte count mean?

With a normal hemoglobin, very little. With anemia, it means the marrow is not producing enough red cells, most often because of iron, vitamin B12 or folate deficiency, kidney disease, chronic inflammation, alcohol, a medication or, less commonly, a disorder of the marrow itself such as aplastic anemia or myelodysplasia. Ferritin, B12, folate and kidney function tests usually identify the cause.

What is the reticulocyte index and how is it calculated?

The reticulocyte index (corrected reticulocyte count) adjusts the raw percentage for anemia: reticulocyte percent × (your hematocrit ÷ 45). The reticulocyte production index (RPI) goes one step further and divides by a maturation factor (1.0 at hematocrit 45, 1.5 at 35, 2.0 at 25, 2.5 at 15) because an anemic marrow releases reticulocytes early. An RPI below 2 means the marrow is underproducing; above 2 to 3 means it is responding appropriately. For example, a retic count of 6 percent with a hematocrit of 25 gives an index of 3.3 and an RPI of about 1.7, which is an inadequate response.

How long after starting iron does the reticulocyte count rise?

Reticulocytes begin to rise within 3 to 5 days of starting adequate oral or intravenous iron in someone who is iron deficient, peak at day 7 to 10 (typically 5 to 15 percent), and then settle as hemoglobin climbs by about 1 g/dL every 2 to 3 weeks. Reticulocyte hemoglobin content (Ret-He) rises even sooner, within 2 to 4 days. If there is no rise by day 10 to 14, absorption, dose, ongoing bleeding or the diagnosis itself needs reviewing.

Is a reticulocyte count of 3 percent high?

Slightly above most laboratories' upper limit of 2 to 2.5 percent. In someone with a normal hemoglobin it is a mild, usually harmless rise seen after blood donation, at altitude, in pregnancy, with intense exercise or with low-grade compensated hemolysis. In someone with a hemoglobin of, say, 9 g/dL it is actually a weak response once corrected for anemia (an RPI of about 1), and would be read as the marrow underproducing rather than overproducing.

Why is the reticulocyte count high in sickle cell disease?

Sickled red cells survive only 10 to 20 days instead of 120, so the marrow runs permanently at several times its normal output and the reticulocyte count sits at 5 to 15 percent in the steady state. That baseline is why a sudden drop toward zero, usually from parvovirus B19 infection shutting production down for a week, is dangerous: hemoglobin can fall by several grams within days (aplastic crisis). People with sickle cell disease are usually prescribed folic acid because the overactive marrow consumes it quickly.

Does a reticulocyte count tell you if you have leukemia?

Not on its own. Leukemia, myelodysplasia and other marrow disorders typically produce a low reticulocyte count with anemia because abnormal cells crowd out normal production, but the same pattern is far more often caused by iron, B12 or folate deficiency, kidney disease or inflammation. The combination of a low count with low white cells or platelets, or abnormal cells on the blood film, is what leads to a bone marrow examination, which is the test that diagnoses leukemia.

References

Reticulocyte count. MedlinePlus, US National Library of Medicine (2023)View source
Evaluation of anemia. Merck Manual Professional Version (2024)
Overview of hemolytic anemia. Merck Manual Professional Version (2024)
Riley RS, Ben-Ezra JM, Goel R, Tidwell A. Reticulocytes and reticulocyte enumeration. Journal of Clinical Laboratory Analysis (2001)
Piva E, Brugnara C, Spolaore F, Plebani M. Clinical utility of reticulocyte parameters. Clinics in Laboratory Medicine (2015)
Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin content. Clinical and Laboratory Haematology (2006)
Killick SB, Bown N, Cavenagh J, et al.. Guidelines for the diagnosis and management of adult aplastic anaemia. British Journal of Haematology (2016)
Short MW, Domagalski JE. Iron deficiency anemia: evaluation and management. American Family Physician (2013)
Camaschella C. Iron-deficiency anemia. New England Journal of Medicine (2015)
Stoffel NU, Cercamondi CI, Brittenham G, et al.. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematology (2017)
Adish AA, Esrey SA, Gyorkos TW, et al.. Effect of consumption of food cooked in iron pots on iron status and growth of young children: a randomised trial. Lancet (1999)
Vitamin B12 fact sheet for health professionals. National Institutes of Health, Office of Dietary Supplements (2024)View source

Related markers

Related conditions

Evidence guides

Worried about your number?

Ask AskMN what your Retic result could mean in the context of your other results, symptoms and medications. Free, unlimited, no account needed.

Ask about my Retic

This page is educational and is not medical advice or a diagnosis. Lab results have to be interpreted together with your history, symptoms and other results by a clinician who knows you. Do not start or stop a supplement to change a lab value before the cause is known.